Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antitrust
Pharma
Trump's nominee to chair the FTC could bode well for pharma M&A
As Donald Trump fills out his cabinet, the President-elect’s latest pick could bode well for biopharma business development over the next four years.
Fraiser Kansteiner
Dec 11, 2024 11:25am
CSL Vifor floats £23M offer to end competition probe in UK
Dec 10, 2024 4:11pm
European officials approve Novo Holdings' planned Catalent buy
Dec 6, 2024 2:48pm
Apotex, Heritage fork over $49M to resolve price-fixing claims
Nov 1, 2024 10:28am
Warren challenges Novo Holdings' proposed Catalent buyout
Oct 10, 2024 2:16pm
Swiss antitrust regulator drops investigation against Novartis
Oct 10, 2024 9:46am
